Published in J Am Coll Cardiol on April 01, 1998
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA (2013) 2.29
Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart (2004) 1.62
CMR for characterization of the myocardium in acute coronary syndromes. Nat Rev Cardiol (2010) 1.04
In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One (2012) 0.98
Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. Heart (2004) 0.96
Non-invasive coronary artery imaging with electron beam computed tomography and magnetic resonance imaging. Heart (2000) 0.96
Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev (2011) 0.94
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol (2011) 0.87
Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol (2010) 0.87
The emerging clinical role of cardiovascular magnetic resonance imaging. Can J Cardiol (2010) 0.87
Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart (2005) 0.86
Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging. World J Cardiol (2014) 0.84
Cardiac magnetic resonance imaging in stable ischaemic heart disease. Neth Heart J (2011) 0.84
Clinical assessment of myocardial hibernation. Heart (2005) 0.83
Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg (2014) 0.83
Diagnostic and imaging considerations: role of viability. Heart Fail Rev (2006) 0.82
Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery. J Cardiovasc Magn Reson (2008) 0.81
The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.81
Cine and tagged magnetic resonance imaging in short-term stunned versus necrotic myocardium. Int J Cardiovasc Imaging (2005) 0.81
Assessment of myocardial ischemia with cardiovascular magnetic resonance. Prog Cardiovasc Dis (2011) 0.81
Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography. Clin Res Cardiol (2010) 0.81
Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2011) 0.80
Cardiac stress MR imaging with dobutamine. Eur Radiol (2006) 0.80
Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction. Heart (2001) 0.80
Hibernating myocardium. Heart (2000) 0.80
Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart (2000) 0.79
Myocardial viability: what we knew and what is new. Cardiol Res Pract (2012) 0.79
Imaging: myocardial thinning is not always transmural scarring. Nat Rev Cardiol (2013) 0.78
Myocardial viability assessed with tagged MRI. MAGMA (2000) 0.78
Cardiovascular imaging in clinical practice: what does late gadolinium enhance? JAMA (2013) 0.77
The role of myocardial viability in contemporary cardiac practice. Heart Fail Rev (2017) 0.77
Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization. J Cardiovasc Magn Reson (2010) 0.76
Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan? Nucl Med Mol Imaging (2013) 0.76
Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques. World J Cardiol (2017) 0.75
Noninvasive imaging of the heart and coronary arteries. Surg Clin North Am (2009) 0.75
Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis. Ont Health Technol Assess Ser (2003) 0.75
Regional myocardial wall thickening assessed at rest by ECG gated (18)F-FDG positron emission tomography and by magnetic resonance imaging. Heart (2000) 0.75
Cardiovascular molecular MR imaging. Eur J Nucl Med Mol Imaging (2007) 0.75
Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J (1999) 0.75
Cardiac magnetic resonance imaging in patients with coronary disease. Curr Treat Options Cardiovasc Med (2008) 0.75
Prediction of myocardial recovery by dobutamine magnetic resonance imaging and delayed enhancement early after reperfused acute myocardial infarction. Eur Radiol (2007) 0.75
Assessment of myocardial viability in a porcine model of chronic coronary artery stenosis with dual dose dobutamine magnetic resonance imaging. Int J Cardiovasc Imaging (2003) 0.75
The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA (2000) 12.26
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation (1992) 3.46
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 2.94
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
[The central venous catheter. Approach to the subclavian vein]. Dtsch Med Wochenschr (2007) 2.04
[Ascites paracentesis]. Dtsch Med Wochenschr (2007) 2.03
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
Symptoms, diagnosis, and therapy of primary sarcomas of the pulmonary artery. Thorac Cardiovasc Surg (1990) 1.89
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
CT and MR evaluation of pericardial constriction: a new diagnostic and therapeutic concept. J Thorac Imaging (1993) 1.64
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol (1999) 1.63
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J (2011) 1.60
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 1.55
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging. Magn Reson Imaging (2000) 1.52
Cine MR imaging: potential for the evaluation of cardiovascular function. AJR Am J Roentgenol (1987) 1.49
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Electron beam computed tomography: on its way into mainstrem cardiology? Eur Heart J (2000) 1.46
Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J (2002) 1.46
Asymptomatic myocardial abscess. Thorac Cardiovasc Surg (1988) 1.45
Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group. J Am Coll Cardiol (1991) 1.44
Morphologic correlate of pathologic Q waves as assessed by gradient-echo magnetic resonance imaging. Am J Cardiol (1994) 1.43
MIBI scintigraphy in hypofunctioning thyroid nodules--can it predict the dignity of the lesion? Nuklearmedizin (2009) 1.42
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J Physiol (1975) 1.42
Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology (1987) 1.41
Xamoterol and the failing heart. Lancet (1989) 1.41
Coronary plaque morphology affects stent deployment: assessment by intracoronary ultrasound. Cathet Cardiovasc Diagn (1996) 1.41
[About science and politics]. Dtsch Med Wochenschr (2003) 1.41
[Therapy with glitazones--a risk for cardiovascular disease?]. Dtsch Med Wochenschr (2007) 1.40
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol (1999) 1.40
[Epileptic seizures: effects on cardiac function]. Dtsch Med Wochenschr (2011) 1.40
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Med Wkly (2009) 1.39
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy]. Dtsch Med Wochenschr (1999) 1.38
[Death due to liver hemorrhage after infarct lysis]. Dtsch Med Wochenschr (1999) 1.38
[Stable angina pectoris can be treated successfully by drugs alone--pro]. Dtsch Med Wochenschr (2007) 1.38
[Missing medical care?]. Dtsch Med Wochenschr (2002) 1.38
Transcatheter closure of atrial-septal defects and patent foramen ovale in adults: optimal anatomic adaptation of occlusion device. Am Heart J (1999) 1.38
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens (2001) 1.29
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart (2008) 1.24
Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery (2000) 1.23
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1998) 1.22
Positive inotropism of vanadate in cat papillary muscle. Nature (1978) 1.18
Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol (1992) 1.18
Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim Biophys Acta (1973) 1.15
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol (1996) 1.12
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation (1999) 1.11
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J (1988) 1.10
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol (1980) 1.08
Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr (1988) 1.07
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood (2001) 1.06
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J (1990) 1.06
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta (1980) 1.05
Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid (1998) 1.04
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet (1992) 1.04
Initial clinical results with the Wiktor stent: a new balloon-expandable coronary stent. Clin Cardiol (1991) 1.04
Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart (2004) 1.04
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. J Clin Invest (1996) 1.04
Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal (1998) 1.01
[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?]. Nuklearmedizin (2008) 1.01
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. Dtsch Med Wochenschr (2005) 1.01
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol (1997) 1.01
Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (1991) 1.01